The Louis A. Johnson VA Medical Center is conducting market research to identify contractors capable of providing contingency hazardous chemotherapy compounding services for its inpatient pharmacy in the event of an IV room shutdown. This is a sources sought notice for planning purposes only and is not a solicitation; responses are voluntary but will inform the government's acquisition strategy. The performance location is the Louis A. Johnson VA Medical Center. Responses, including a capability statement and business details, must be submitted via email by 3:00 p.m. Eastern Standard Time on March 25, 2026. No budget information is specified in this notice.